UA74341C2 - Похідні борелідину, які інгібують ангіогенез - Google Patents

Похідні борелідину, які інгібують ангіогенез

Info

Publication number
UA74341C2
UA74341C2 UA2002010814A UA200210814A UA74341C2 UA 74341 C2 UA74341 C2 UA 74341C2 UA 2002010814 A UA2002010814 A UA 2002010814A UA 200210814 A UA200210814 A UA 200210814A UA 74341 C2 UA74341 C2 UA 74341C2
Authority
UA
Ukraine
Prior art keywords
group
compounds
general formula
inhibiting angiogenesis
stands
Prior art date
Application number
UA2002010814A
Other languages
English (en)
Russian (ru)
Inventor
Нандор МАКК
Габор АМБРУС
Аніко Тегдес
Андраш Еней
Ференц Тімар
Original Assignee
Івакс Драг Рісерч Інститьют Лімітед Лайебіліті Компані
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Івакс Драг Рісерч Інститьют Лімітед Лайебіліті Компані filed Critical Івакс Драг Рісерч Інститьют Лімітед Лайебіліті Компані
Publication of UA74341C2 publication Critical patent/UA74341C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

( І ) Винахід стосується сполук загальної формули (I), де R - група загальної формули -COOR1, -CONR2R3, -CONR4CONR4R5 aбo -CH2OR6, де R1 - С2-6 алкільна група; С1-6 заміщена алкільна група; або С3-6 циклоалкільна група; R2 i R3 - однакові або різні й незалежно одно від одної є атомом водню або С1-6 алкільною групою, яка необов'язково може бути заміщена; 5- або 6-членна циклоалкільна або гетероарильна група; та їх таутомери, сольвати й суміші, а також адитивно-кислотні солі цих сполук. Винахід також стосується фармацевтичних композицій, що містять сполуки загальної формули (І) як активний агент. Ангіогенез-інгібітори згідно з винаходом інгібують неоваскуляризацію в живих тканинах і, як такі, можуть бути використані для запобігання й інгібування ангіогенезу, що з'явився у зв'язку з ростом пухлин і для запобігання утворенню метастазів пухлин.
UA2002010814A 1999-08-02 2000-08-02 Похідні борелідину, які інгібують ангіогенез UA74341C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902628A HUP9902628A3 (en) 1999-08-02 1999-08-02 Angiogenesis inhibiting borrelidin derivatives, their use and pharmaceutical compositions containing them
PCT/HU2000/000088 WO2001009113A2 (en) 1999-08-02 2000-08-02 Heterocyclic compounds inhibiting angiogenesis

Publications (1)

Publication Number Publication Date
UA74341C2 true UA74341C2 (uk) 2005-12-15

Family

ID=89998954

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002010814A UA74341C2 (uk) 1999-08-02 2000-08-02 Похідні борелідину, які інгібують ангіогенез

Country Status (32)

Country Link
US (1) US6815465B1 (uk)
EP (1) EP1206462B1 (uk)
JP (1) JP2003506366A (uk)
KR (1) KR20020068495A (uk)
CN (1) CN1243746C (uk)
AP (1) AP1383A (uk)
AT (1) ATE241611T1 (uk)
AU (1) AU772206B2 (uk)
BG (1) BG106373A (uk)
BR (1) BR0012968A (uk)
CA (1) CA2378176A1 (uk)
CZ (1) CZ2002405A3 (uk)
DE (1) DE60003045T2 (uk)
DK (1) DK1206462T3 (uk)
ES (1) ES2200900T3 (uk)
HK (1) HK1048995B (uk)
HR (1) HRP20020103B1 (uk)
HU (1) HUP9902628A3 (uk)
IL (1) IL147904A (uk)
IS (1) IS2137B (uk)
MX (1) MXPA02001117A (uk)
NO (1) NO20020485L (uk)
NZ (1) NZ517422A (uk)
OA (1) OA12004A (uk)
PL (1) PL354281A1 (uk)
PT (1) PT1206462E (uk)
RU (1) RU2247723C2 (uk)
SK (1) SK1822002A3 (uk)
UA (1) UA74341C2 (uk)
WO (1) WO2001009113A2 (uk)
YU (1) YU7302A (uk)
ZA (1) ZA200200838B (uk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
ATE452896T1 (de) 2002-03-12 2010-01-15 Bristol Myers Squibb Co C3-cyanoepothilonderivate
GB0230217D0 (en) * 2002-12-27 2003-02-05 Biotica Tech Ltd Borrelidin-producing polyketide synthase and its uses
US8440217B1 (en) 2005-06-15 2013-05-14 Mawaheb M. EL-Naggar Method and system with contact lens product for treating and preventing adverse eye conditions
GB0609981D0 (en) * 2006-05-19 2006-06-28 Biotica Tech Ltd Novel compounds
GB0713563D0 (en) * 2007-07-13 2007-08-22 Biotica Tech Ltd Methods of screening for anti-angiogenic compounds
MX2010001462A (es) * 2007-08-27 2010-03-01 Basf Se Compuestos de pirazol para controlar plagas de invertebrados.
DE102008014077A1 (de) 2008-03-13 2009-09-17 Discovery Partner International Gmbh Borrelidin-Derivate
WO2009141786A2 (en) * 2008-05-21 2009-11-26 Piramal Life Sciences Limited Anti-inflammatory compounds
EP3492499A1 (en) 2014-12-15 2019-06-05 Borealis AG Melt-blown webs without shots and with improved barrier properties

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08173176A (ja) * 1994-12-22 1996-07-09 Mercian Corp 血管新生阻害剤
JP3786461B2 (ja) * 1996-02-22 2006-06-14 メルシャン株式会社 新生理活性物質

Also Published As

Publication number Publication date
NO20020485L (no) 2002-03-21
PL354281A1 (en) 2003-12-29
RU2247723C2 (ru) 2005-03-10
HUP9902628A3 (en) 2001-07-30
HRP20020103B1 (en) 2005-06-30
PT1206462E (pt) 2003-10-31
YU7302A (sh) 2004-09-03
CN1243746C (zh) 2006-03-01
AU6309000A (en) 2001-02-19
ES2200900T3 (es) 2004-03-16
MXPA02001117A (es) 2003-08-20
HUP9902628A2 (hu) 2001-05-28
BG106373A (en) 2002-09-30
DK1206462T3 (da) 2003-09-29
WO2001009113A3 (en) 2001-06-14
IS6258A (is) 2002-02-01
AP2002002413A0 (en) 2002-03-31
NZ517422A (en) 2005-02-25
US6815465B1 (en) 2004-11-09
KR20020068495A (ko) 2002-08-27
DE60003045T2 (de) 2004-04-01
ZA200200838B (en) 2003-08-27
IL147904A0 (en) 2002-08-14
AP1383A (en) 2005-04-05
EP1206462B1 (en) 2003-05-28
CZ2002405A3 (cs) 2002-07-17
CN1372556A (zh) 2002-10-02
JP2003506366A (ja) 2003-02-18
ATE241611T1 (de) 2003-06-15
EP1206462A2 (en) 2002-05-22
HK1048995B (zh) 2006-07-21
HU9902628D0 (en) 1999-10-28
AU772206B2 (en) 2004-04-22
IL147904A (en) 2005-09-25
HRP20020103A2 (en) 2004-02-29
CA2378176A1 (en) 2001-02-08
WO2001009113A2 (en) 2001-02-08
OA12004A (en) 2006-04-18
NO20020485D0 (no) 2002-01-30
DE60003045D1 (de) 2003-07-03
BR0012968A (pt) 2002-05-14
IS2137B (is) 2006-08-14
HK1048995A1 (en) 2003-04-25
SK1822002A3 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
BG66087B1 (bg) Хинолинонови производни като тирозин киназни инхибитори
AU2001235844A1 (en) Imidazol-2-carboxamide derivatives as raf kinase inhibitors
DE60008206D1 (de) Chinolinderivate verwendbar zur Hemmung der Farnesyl-Protein Transferase
AU2001235838A1 (en) Imidazol derivatives as raf kinase inhibitors
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
ATE321038T1 (de) Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
MX2009000675A (es) Concentrados acuosos de principios activos con efecto herbicida.
TW200616636A (en) Novel compounds
AU7652101A (en) Cinnoline compounds
ATE319704T1 (de) Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate
CA2336412A1 (en) Medicament for treatment of diabetes
UA74341C2 (uk) Похідні борелідину, які інгібують ангіогенез
FI951858A0 (fi) Kinoloni- ja akridonijohdannaisia virtsanpidätyskyvyttömyyden hoidossa
DK1233953T3 (da) Nye benzoethiadiazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende samme
TR200103789T2 (tr) Tirozin kinaz inhibitörleri olarak ikameli 1,4-dihidroindeno[1,2-C]pirazoller.
EA200400896A1 (ru) Терапевтические акридоновые и акридиновые соединения
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
FR2672213B1 (fr) Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres.
HU0301173D0 (en) Quinazoline derivatives and their use for the preparation of pharmaceutical compositions inhibiting parp enzyme
MY136694A (en) New thiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
TW200621227A (en) Medicament for preventing or treating fatty liver
RS20050954A (en) Use of bycyclo/2.2.1/heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
IL115085A0 (en) Bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them
HUP0100751A2 (hu) Új aril-vagy heteroaril-kinolinilfoszfonsav-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények